Although the small bowel represents 75 % of the length and 90 % of the overall mucosal surface of the alimentary tract, it is considered a rare loca− tion for the development of neoplasms, account− ing for only 1 % ± 3 % of all primary gastrointesti− nal tumors [1, 2] . A review of the Utah Cancer Registry from 1966 through 1990 showed that the overall age−adjusted yearly incidence of small−bowel cancers was 1.4 per 100 000. Over a 30−year period [3] , Barclay [4] reported an inci− dence of 0.7/0.6 (male/female) malignant small− bowel tumors per 100 000, which accounted for 1.6 % of all gastrointestinal tumors [5] . Approximately 40 different histological types of small−intestinal tumors have been identified [6] . Among malignant tumors, about 30 % ± 50 % are adenocarcinomas, 25 % ± 30 % are carcinoids, and 15 % ± 20 % are lymphomas. The majority of be− nign small−bowel tumors originate from the stro− mal layer [7] accounting for about 15 % ± 20 % of all small−bowel primary neoplasms [8, 9] . Secondary neoplasia has been reported to be more frequent than primary small−intestinal neoplasms. Primary tumors of the colon, ovary, uterus, and stomach can metastasize to the small bowel by direct invasion or by intraperitoneal spread, whereas primaries from breast, lung, and melanoma metastasize by the hematogenous route [7] . In patients with skin melanoma, small−bowel metastases have been described in 1.5 % ± 4.4 % of cases in in−vivo studies [10, 11] and in 58 % of post−mortem specimens [10] . Small−bowel tumors grow slowly, extraluminally, remaining asymptomatic for years or presenting insidiously in patients with nonspecific com− plaints such as abdominal pain, diarrhea, iron de− Background and study aim: Small−bowel tumors account for 1 % ± 3 % of all gastrointestinal neo− plasms. Recent studies with video capsule endos− copy (VCE) suggest that the frequency of these tumors may be substantially higher than pre− viously reported. The aim of the study was to evaluate the frequency, clinical presentation, di− agnostic/therapeutic work−up, and endoscopic appearance of small−bowel tumors in a large population of patients undergoing VCE. Patients and methods: Identification by a ques− tionnaire of patients with VCE findings suggest− ing small−bowel tumors and histological confir− mation of the neoplasm seen in 29 centers of 10 European Countries. Results: Of 5129 patients undergoing VCE, 124 (2.4 %) had small−bowel tumors (112 primary, 12 metastatic). Among these patients, indications for VCE were: obscure gastrointestinal bleeding (108 patients), abdominal pain (9), search for pri− mary neoplasm (6), diarrhea with malabsorption (1). The main primary small−bowel tumor type
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Although the small bowel represents 75 % of the length and 90 % of the overall mucosal surface of the alimentary tract, it is considered a rare loca− tion for the development of neoplasms, account− ing for only 1 % ± 3 % of all primary gastrointesti− nal tumors [1, 2] . A review of the Utah Cancer Registry from 1966 through 1990 showed that the overall age−adjusted yearly incidence of small−bowel cancers was 1.4 per 100 000. Over a 30−year period [3] , Barclay [4] reported an inci− dence of 0.7/0.6 (male/female) malignant small− bowel tumors per 100 000, which accounted for 1.6 % of all gastrointestinal tumors [5] . Approximately 40 different histological types of small−intestinal tumors have been identified [6] . Among malignant tumors, about 30 % ± 50 % are adenocarcinomas, 25 % ± 30 % are carcinoids, and 15 % ± 20 % are lymphomas. The majority of be− nign small−bowel tumors originate from the stro− mal layer [7] accounting for about 15 % ± 20 % of all small−bowel primary neoplasms [8, 9] . Secondary neoplasia has been reported to be more frequent than primary small−intestinal neoplasms. Primary tumors of the colon, ovary, uterus, and stomach can metastasize to the small bowel by direct invasion or by intraperitoneal spread, whereas primaries from breast, lung, and melanoma metastasize by the hematogenous route [7] . In patients with skin melanoma, small−bowel metastases have been described in 1.5 % ± 4.4 % of cases in in−vivo studies [10, 11] and in 58 % of post−mortem specimens [10] . Small−bowel tumors grow slowly, extraluminally, remaining asymptomatic for years or presenting insidiously in patients with nonspecific com− plaints such as abdominal pain, diarrhea, iron de− Background and study aim: Small−bowel tumors account for 1 % ± 3 % of all gastrointestinal neo− plasms. Recent studies with video capsule endos− copy (VCE) suggest that the frequency of these tumors may be substantially higher than pre− viously reported. The aim of the study was to evaluate the frequency, clinical presentation, di− agnostic/therapeutic work−up, and endoscopic appearance of small−bowel tumors in a large population of patients undergoing VCE. Patients and methods: Identification by a ques− tionnaire of patients with VCE findings suggest− ing small−bowel tumors and histological confir− mation of the neoplasm seen in 29 centers of 10 European Countries. Results: Of 5129 patients undergoing VCE, 124 (2.4 %) had small−bowel tumors (112 primary, 12 metastatic). Among these patients, indications for VCE were: obscure gastrointestinal bleeding (108 patients), abdominal pain (9), search for pri− mary neoplasm (6), diarrhea with malabsorption (1). The main primary small−bowel tumor type was gastrointestinal stromal tumor (GIST) (32 %) followed by adenocarcinoma (20 %) and carcinoid (15 %); 66 % of secondary small−bowel tumors were melanomas. Of the tumors, 80.6 % were identified solely on the basis of VCE findings. 55 patients underwent VCE as the third procedure after negative bidirectional endoscopy. The le− sions were single in 89.5 % of cases, and multiple in 10.5 %. Retention of the capsule occurred in 9.8 % of patients with small−bowel tumors. After VCE, 54/124 patients underwent 57 other exami− nations before treatment; in these patients en− teroscopy, when performed, showed a high diag− nostic yield. Treatment was surgery in 95 % of cases. Conclusions: Our data suggest that VCE detects small−bowel tumors in a small proportion of pa− tients undergoing this examination, but the early use of this tool can shorten the diagnostic work− up and influence the subsequent management of these patients. ficiency anemia, bleeding, extraintestinal symptoms (flushing, paraneoplastic syndromes), or acute obstruction [12] . In these patients, the results of routine diagnostic laboratory and other diagnostic tests, such as push enteroscopy, small−bowel series (SBS) or enteroclysis, computed tomography, and magnetic reso− nance imaging may frequently be inconclusive. For these rea− sons the diagnosis is often delayed [6, 12] , thus failing to prevent the development of locally advanced lesions or metastatic dis− ease. The development and clinical implementation of video capsule endoscopy (VCE), an accurate, safe, and painless method of en− doscopically evaluating all of the small bowel, has opened a new frontier in the field of small−bowel investigation. Since the introduction of this device into clinical practice, a few small ser− ies have been published showing an frequency of small−bowel neoplasms higher than previously expected, ranging between 2 % and 9 % [13 ± 17] , and some authors have speculated that rou− tine use of wireless capsule endoscopy in the diagnostic algo− rithm for obscure gastrointestinal bleeding, iron deficiency ane− mia, and abdominal pain would lead to earlier diagnosis, and therefore improve the overall prognosis associated with malig− nant small−bowel tumors [18] . The aim of the present study was to describe the frequency, clin− ical presentation, endoscopic appearance, and diagnostic work− up related to small−bowel tumors in a large population of pa− tients undergoing VCE.
Patients and methods
!
This study was carried out in 29 centers from 10 European coun− tries. Each participating center reviewed its own series of conse− cutive patients undergoing VCE, from the beginning of the use of this device in clinical practice until October 2006. For each patient in whom VCE showed one or more lesions sug− gesting small−bowel neoplasia, and a subsequent diagnostic/ therapeutic work−up led to histological confirmation, a specific structured questionnaire was completed. We decided to exclude from the study all patients with a known condition that increases the risk of small−bowel neoplasms (e. g. patients with refractory celiac disease or patients with familial adenomatous polyposis [FAP] or Peutz±Jeghers syndrome with alarm symptoms or under surveillance). The questionnaire collected data on: " the center where VCE was performed (name of referring physician, number of VCE procedures performed at the time of data submission), " the patient (age, sex, and length of clinical history), " indication for VCE (for patients with obscure gastrointestinal bleeding [OGIB], their hemoglobin level at the time of VCE), " diagnostic work−up before VCE, " results of VCE (endoscopic appearance of the lesion, and lo− cation, estimated by the physician reviewing the video), " complications related to VCE (e. g. capsule retention), " diagnostic−therapeutic work−up after VCE (particularly a brief description of surgical intervention, if done, with appearance and location of the lesion), " final histological diagnosis.
Statistical analysis
This was done using SPSS software (SPSS 14.0 for Windows, SPSS Inc. Chicago, Illinois, USA). To describe the population, we used mean and SD for data with a Gaussian distribution (e. g. age) and median and range for data with a non−Gaussian distribution (e. g. length of clinical history). To compare unpaired groups, we used the two−tailed t test for unpaired groups or the Mann± Whitney test, respectively, for data with Gaussian or non−Gaus− sian distributions. The Spearman correlation test was used to quantify the associa− tion between variables. We calculated the value of r, which ranges between + 1 and ± 1; a value of 0 means that the two vari− ables do not vary together at all, while + 1 or ± 1 indicate perfect correlation (respectively, direct or inverse). To analyze contingency tables we used the C 2 test or Fisher's ex− act test as appropriate. As usual, for all these tests, a P value of less than 0.05 was considered to be statistically significant.
Results
!
Frequency of small−bowel tumors
In 29 centers from 10 European countries, 5129 VCE examina− tions were performed, for any indication. Unfortunately we did not know when each center started to use VCE in clinical prac− tice; thus we were not able to calculate the mean rate of exami− nations performed per center per year but only the total number of VCEs done at each center. From the 5129 examinations (l " Ta− ble 1), we collected data on 160 patients. A total of 36 question− naires were excluded from further evaluation: 13 described small−bowel neoplasms in patients with refractory celiac disease (n = 8) or Peutz±Jeghers syndrome (n = 5), while 23 were incom− plete. Thus, data from a total of 124 patients (mean age SD 60.3 14.3 years) with histologically proven small−bowel neo− plasms were evaluated. The overall frequency of small−bowel tumors identified at VCE was 2.4 %, ranging between 0.75 % (3/400) and 9.3 % (7/75) for the 29 centers. We found an inverse correlation (Spearman r = ± 0.56, 95 % confidence interval [CI] ± 0.77 to ± 0.23; P < 0.002; l " Fig. 1 ) between the frequency of identification of small−bowel neoplasms and the number of VCE examinations performed at each center.
Indication for VCE
The indication for VCE was obscure gastrointestinal bleeding (OGIB) in 108 patients (108/124, 87.1 %), which was obscure−oc− cult in 52 (52/108, 48.2 %), ongoing overt in 36 (36/108, 33.3 %) and previous overt in 20 (20/108, 18.5 %) . In the remaining 16 pa− tients (16/124, 12.9 %), the indication for VCE was abdominal pain in 9, investigation for primary neoplasms in patients with liver metastases or carcinoid syndrome in 6, and diarrhea with severe malabsorption in 1.
Diagnostic work−up before VCE
Of the 124 patients, 55 (44.4 %) underwent VCE as the third ex− amination after negative bidirectional endoscopy, while the re− maining 69 (55.6 %) had undergone at least one further examina− tion aimed to evaluate the small−bowel before VCE. These 69 pa− tients underwent 102 examinations specifically addressed to evaluate the small bowel (not including repeated gastroscopies and colonoscopies) before capsule endoscopy (mean number of diagnostic procedures per patient, 1.47); in 45 out of these 69 pa− Original article 489 tients the diagnostic work−up was completely negative while 24 patients had at least one examination with positive results. The examinations performed before VCE and their diagnostic yield are shown in l " Table 2 . Taking together the patients who underwent VCE immediately after negative bidirectional endoscopy (n = 55) and the patients with a negative diagnostic work−up despite further examina− tions (n = 45), capsule endoscopy had a direct impact on diagno− sis, identifying an unexpected small−bowel tumor, in 80.6 % of patients (100/124).
Endoscopic appearance and histological classification
The endoscopic appearance of lesions identified by VCE was: polyp or mass in 94 patients (75.8 %); ulcers in 10 (8.1 %); fresh blood in 8 (6.5 %); stenoses in 8 (6.5 %); and cobblestone in 4 (3.2 %). l " Fig. 2 shows a polypoid, ulcerated lesion that was con− firmed at surgical intervention (l " Fig. 3 ). These lesions were single in 111 cases (89.5 %) and multiple in 13 (10.5 %) Of 124 lesions identified, 112 were primary neoplasms (112/5129 or 2.2 %) while the other 12 cases were small−bowel metastases (12/5129 or 0.2 %). The most frequent histological type of pri− mary tumors was gastrointestinal stromal tumor (GIST) (32.1 %) followed by adenocarcinoma (20.5 %) and carcinoid (15.6 %). In 8 out of 12 cases with metastatic small−bowel tumors, the metas− tases were from a previously removed skin melanoma. The his− tological classification of the small−bowel primary neoplasms and metastases is shown in l " Table 3 .
Location of tumors
On the basis of further diagnostic and/or therapeutic work up carried out after VCE, the definitive location of single lesions was established as the jejunum in 70.3 % of cases, the ileum in 22.5 %, and the duodenum in 7.2 %. There was 92.8 % agreement (103/111 cases) between the location of single lesions as asses− sed by VCE and that established on the basis of further diagnos− tic and/or therapeutic work−up.
Complications of capsule endoscopy
All patients enrolled in this study (except one in whom the cap− sule was placed in the stomach using the endoscope), swallowed the capsule easily. Among the 38 patients (30.9 %) in whom the 
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capsule did not reach the ileocecal valve during the examination period, in 12 (12/124, 9.7 %) the capsule was stuck at the site of the tumor. Five of these 12 patients (41.6 %) had undergone an SBS or small−bowel enteroclysis before VCE, with negative re− sults. In 2/12 patients (16 %) the capsule was retrieved with the push enteroscope and in 10 (84 %) by surgical intervention. The relevant data for these 12 patients is presented in l " Table 4 .
Capsule retention occurred only in patients with stenoses (n = 6) or polyps/masses (n = 6). As expected, stenoses led to cap− sule retention more frequently than polyps/masses (6 cases of retention in 8 patients with stenoses vs. 6 in 94 with polyps/ masses; Fisher test, P = 0.002). There was no difference in the occurrence of retention according to type of OGIB, location, or histological type of tumor. None of these 12 patients had acute obstruction due to capsule retention. In the remaining 26 patients, in whom the capsule did not reach the ileocecal valve during the examination period but was not retained, the capsule was egested naturally in the stool within 7 ± 15 days.
Diagnostic and therapeutic work up after capsule endoscopy
A total of 110 patients were treated by surgery alone, 8 received a combination of surgery and chemotherapy, 1 underwent endo− scopic polypectomy, while 1 was left untreated because of poor general condition and 4 were lost to follow−up. Among 112 pa− tients without capsule retention, treatment was given directly after VCE in 58 patients, while 54 underwent further examina− tions (l " Table 2 ), which were negative in 9. Thus, in 67 patients therapy was done solely on the basis of the diagnosis made by VCE, in 35 it was based also on the results of further tests, while 12 underwent operation following capsule retention.
Discussion
!
Since the introduction of VCE in clinical practice, several studies have shown that the performance of this technique is superior to that of other diagnostic modalities in detecting small−bowel ab− normalities including vascular lesions, inflammation and tu− mors [19 ± 22] . Nowadays, it is well accepted that VCE plays a key role in the diagnostic work−up of obscure gastrointestinal bleeding, in the diagnosis of suspected Crohn's disease and in the evaluation of the small bowel in patients with refractory ce− liac disease, but the role of capsule endoscopy in the diagnosis and management of small−bowel tumors is still debated, despite a growing body of evidence in this field [13 ± 18] . The aim of the present study was to describe the frequency, clin− ical presentation, endoscopic appearance, and diagnostic work− up of small−bowel tumors in a population that was as large as possible of patients undergoing VCE. For this purpose, the study protocol was sent to all members of the European Capsule En− doscopy Group (ECEG) and a specific notice was placed in the home page of the website www.capsuleendoscopy.org. On the one hand, this method of data collection allowed us to create the largest database published so far of small−bowel tumors de− tected by capsule endoscopy (124 tumors with 5129 capsule pro− cedures performed); on the other hand, this led to the inclusion of a group of centers that were heterogeneous (in terms of num− ber of patients referred for VCE, number of tumors identified, number of capsule examinations performed, and the diagnostic and therapeutic work−up done before and after VCE). The fact that the majority of cases came from Italy and Spain is probably due to the existence in both countries of a capsule endoscopy study group that facilitated case collection. In our study the frequency of small−bowel tumors (2.4 %) was surprisingly and substantially lower than that reported in other studies in which, as in the present one, the authors collected both benign and malignant neoplasms [13 ± 16,18,19] . The strict patient selection (particularly the requirement for histological confirmation of lesions identified by capsule endoscopy, and the exclusion of patients with a high pre−test probability of hav− ing a tumor) could be a possible explanation for this difference. On the other hand, while our series is comparable to the other published series [13 ± 19] in terms of age and gender of the pa− tients and of clinical indication for VCE, an important difference is the number of VCE examinations performed, which in our study is almost ten times larger than that of the largest previous− ly published series. To ascertain whether the number of exami− nations is in any way related to the frequency of tumor detec− tion, we examined the relationship between frequency of tu− mors found and number of VCE examinations performed in the centers participating in the study. Indeed, this analysis revealed a significant inverse correlation (Spearman r = ± 0.56, P < 0.002; l " Fig. 1) , suggesting that the high number of VCEs carried out might in some way be related to the low frequency of tumor de− tection that we found. Interestingly, our figures are in keeping with those of the second largest existing study, by Pasha et al. [23] , that was recently presented at an international meeting; this included 1000 VCE examinations, with a 1.6 % frequency of small−bowel tumors. There is no obvious explanation for this. It is possible that centers where fewer examinations were carried out adopted stricter criteria for patient selection than larger cen− ters; however, the characteristics of the patients enrolled in the different participating centers in our study were homogeneous. In our series, as in other studies, OGIB was the leading indication for capsule endoscopy. This was expected, since OGIB is the indi− cation for VCE in 65 % ± 100 % of cases in all published series [13, 18] . The design of the study does not allow estimation of the sensi− tivity and specificity of capsule endoscopy for small−bowel tu− mors. Recently published studies with double−balloon enteros− copy (DBE) [24] clearly demonstrated that capsule endoscopy can miss even large malignant masses (a pooled analysis of pre− viously published studies [21] showed a miss rate of up to 18.9 %). On the other hand, the difficulties in distinguishing bul− ges from masses underline the main limitation of capsule endos− copy, i. e. the inability to take biopsies. Furthermore, we could not evaluate the role of DBE in confirming or disproving the di− agnoses made by capsule endoscopy, since during the collection of our cases DBE was not widely available at the participating centers. Despite these limitations, our study confirms that nowadays capsule endoscopy is often used as the third examina− tion (in about 50 % of patients) after a negative bidirectional en− doscopy, especially in patients with obscure gastrointestinal bleeding [19, 25, 26] . As far as the diagnostic work−up before VCE is concerned, all our patients underwent at least one gastroscopy and one colonosco− py with negative results. In the present study, we focused on the alternative techniques to conventional endoscopy that were in− cluded in the work−up of patients before capsule endoscopy, be− cause we were interested in assessing their diagnostic perform− ance for small−bowel tumors. The mean number of examina− tions performed in 69 patients who underwent other diagnostic tests before VCE, excluding repeated bidirectional endoscopy, is comparable with those reported in other studies [13 ± 15,17 ± 19] (range 1.28±1.57), as is the percentage of patients in whom other diagnostic techniques failed to identify the neoplasm (about 65 %) [15] . Concerning the impact of VCE on diagnosis, we were conservative and counted only the patients in whom VCE showed a tumor undetected by other techniques. Nevertheless, 80 % of tumors were identified solely by VCE, and this figure is much higher than that reported by others [17] . Enteroscopy (both push and balloon enteroscopy) was seldom performed be− fore VCE, and had a low diagnostic yield (l " Table 2 ; 1/11, 9 %). On the other hand, when conventional enteroscopy (push or DBE) was performed after a positive VCE examination, the diagnostic yield rose sharply (l " Table 2 ; 27/35, 77 %; P = < 0.0001), suggest− ing that VCE can be useful in indicating the utility of convention− al endoscopy for obtaining tissue samples. As reported in other recently published series [13 ± 18] , adeno− carcinomas, GISTs, carcinoids and lymphomas account for about 90 % of small−bowel neoplasms. The most frequent tumor type in our series was GIST. When it is located in the small bowel, it is generally considered to be malignant in about 50 % of cases; however, from an oncological standpoint, GISTs form a conti− nuum. In general, size and mitotic activity [27, 29] are used to judge the oncologic potential of these tumors. Unfortunately, we do not have mitotic activity data for the GISTs in our series, and therefore we decided not to classify them as malignant or benign. Our study also confirms the high tropism of skin mela− noma for the small−bowel mucosa [10,11,13 ± 16,18, 30, 31] . As expected, the majority of small−bowel tumors in our study were lesions that protruded into the lumen located in the jeju− num, an area that is difficult to evaluate with other diagnostic techniques. Since confirmation of the diagnosis was obtained in all cases by conventional endoscopic or surgical means, we were able to compare the location of the lesion as assessed by the VCE reviewer with that found at endoscopy or surgery: in patients with a single lesion we found an impressive agreement (92.8 %), which is comparable with that reported by Pasha et al. [23] . Among the eight cases in which the location of the lesion was misjudged at capsule endoscopy, in four cases the lesion was more proximal than expected on the basis of the capsule exami− nation and in four cases it was more distal. We did not use the standard definition of capsule retention [32] , i. e. retention of the capsule in the small intestine for more than 15 days, because in some cases the procedure planned to solve the clinical problem was performed earlier than 15 days from in− gestion. Therefore, we defined capsule retention as having oc− curred when the videos showed repetitive images, suggesting stenosis, and the capsule was retrieved at the site of the lesion by surgery or push enteroscopy. According to these criteria, cap− sule retention occurred in about 10 % of cases. This rate is similar to the 11.5 % reported by Bailey et al. [15] and substantially high− er than those reported by Urbain et al. [17] and Cobrin et al. (0 %) [14] , while Pasha et al. [23] reported a very high occurrence (about 25 %) of capsule retention in patients with small−bowel tumors. We do not have a obvious explanation for these differences among studies. As reported in several studies [32, 34] a negative SBS or enteroclysis performed before VCE does not guarantee the passage of the capsule: in our series five patients with capsule retention had undergone an SBS or enteroclysis with negative findings before the VCE. Acute obstruction due to capsule retention is a rare complication [35] of capsule endoscopy and capsule retention can be consid− ered, particularly in this subset of patients who often require surgical intervention, as a "positive complication" leading to di− agnosis. None of our patients with capsule retention experi− enced acute obstruction, as reported also by Bailey et al. [15] . We can hypothesize that in patients with small−bowel tumors, the slow growth and the development of pre−stenotic dilatation, often described at the time of surgical intervention, can prevent acute obstruction. The development of a dissolvable capsule to
Original article 493 test bowel patency, by Given Imaging (Yoqneam, Israel) [37 ± 41] , and the recently achieved possibility of retrieving retained cap− sules with DBE [36] , will probably decrease the occurrence and clinical consequences of this complication. Capsule endoscopy appears thus to be appropriate as the first step in the diagnostic process of small−bowel tumors, since it may direct further diagnostic procedures (push enteroscopy, DBE) aimed at obtaining tissue: in our series this led to a defini− tive histologic diagnosis in 77 % ± 80 % of cases. In addition, cap− sule endoscopy has a direct impact on therapy, since 60 % of our patients in whom the capsule was not retained underwent surgi− cal or endoscopic therapy immediately following capsule endos− copy. At present, surgery is by far the most frequently used treat− ment in these patients [14 ± 18, 23] .
Whether the timely and widespread use of capsule endoscopy in patients with obscure gastrointestinal bleeding or other unex− plained abdominal complaints will lead to the earlier identifica− tion of patients with small−bowel tumors, resulting ultimately in a survival benefit for the patients, will have to be clarified in spe− cifically designed studies. Such studies will help define the best diagnostic/therapeutic algorithm for these patients, and the place of capsule endoscopy in such an algorithm.
